Literature DB >> 9885905

CD80 expression is decreased in hyperplastic lymph nodes of HIV+ patients.

C Legendre1, M Raphael, G Gras, E A Lefevre, J Feuillard, D Dormont, Y Richard.   

Abstract

A centrofollicular hyperplasia is present within secondary lymphoid organs during all the asymptomatic phase of the HIV disease. Although this hyperplasia has been well characterized by histological studies, the nature of the phenotypic alterations in B cell populations occurring within HIV+ lymphoid organs remains to be established. By immunohistochemistry, we thus investigated whether a particular germinal center (GC) B cell population was increased during HIV-induced hyperplasia and whether any phenotypic change was specific to HIV-1 infection. As compared to normal tonsils (three cases) and HIV- hyperplastic lymph nodes (eight patients), we observed a loss of GC polarization in all HIV+ sections (11 patients), with no more delineation between dark and light zones, as shown by Ki67, CD10, CD77, CD95 and CD86 staining. In contrast to CD86 expression which remained as intensive in HIV+ as in HIV- lymph nodes, CD80 staining was strongly decreased in GC of HIV+ lymph nodes but not in their extrafollicular zones. The loss of CD80 expression from CD19+ B cells was also observed by cytometric analysis of cell suspensions of three HIV+ patients. Although we found no evidence of an increase in a particular GC B cell subset in HIV-1-induced hyperplasia, the strong GC disorganization observed may induce impaired cell-cell interactions and thus participate in the loss of CD80 antigen. In contrast to HIV- situations where CD80 and CD86 was similarly expressed on B cells, the lower level of CD80 expression in HIV+ GC may favor Th2 T cell responses through CD86-CD28 interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9885905     DOI: 10.1093/intimm/10.12.1847

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

Review 1.  Studies of HIV-associated immune responses in lymphoid compartments.

Authors:  Susanna Grundström; Jan Andersson
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

2.  High frequency of virus-specific B lymphocytes in germinal centers of simian-human immunodeficiency virus-infected rhesus monkeys.

Authors:  David H Margolin; Erika F Helmuth Saunders; Benjamin Bronfin; Nicole de Rosa; Michael K Axthelm; Xavier Alvarez; Norman L Letvin
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 3.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  Default in plasma and intestinal IgA responses during acute infection by simian immunodeficiency virus.

Authors:  Nada Chaoul; Chantal Burelout; Sandrine Peruchon; Beatrice Nguyen van Buu; Pascale Laurent; Alexis Proust; Martine Raphael; Olivier Garraud; Roger Le Grand; Sophie Prevot; Yolande Richard
Journal:  Retrovirology       Date:  2012-05-25       Impact factor: 4.602

Review 5.  Subversion of the B-cell compartment during parasitic, bacterial, and viral infections.

Authors:  Gwenoline Borhis; Yolande Richard
Journal:  BMC Immunol       Date:  2015-03-26       Impact factor: 3.615

6.  Marginal zone B-cells, a gatekeeper of innate immunity.

Authors:  Moncef Zouali; Yolande Richard
Journal:  Front Immunol       Date:  2011-12-13       Impact factor: 7.561

7.  Tissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infection.

Authors:  Sandrine Peruchon; Nada Chaoul; Chantal Burelout; Benoit Delache; Patricia Brochard; Pascale Laurent; Fabrice Cognasse; Sophie Prévot; Olivier Garraud; Roger Le Grand; Yolande Richard
Journal:  PLoS One       Date:  2009-06-19       Impact factor: 3.240

8.  The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression.

Authors:  Katija Jelicic; Raffaello Cimbro; Fatima Nawaz; Da Wei Huang; Xin Zheng; Jun Yang; Richard A Lempicki; Massimiliano Pascuccio; Donald Van Ryk; Catherine Schwing; Joseph Hiatt; Noreen Okwara; Danlan Wei; Gregg Roby; Antonio David; Ii Young Hwang; John H Kehrl; James Arthos; Claudia Cicala; Anthony S Fauci
Journal:  Nat Immunol       Date:  2013-10-27       Impact factor: 25.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.